185 General discussion 7 46. Teo K, Lear S, Islam S, Mony P, Dehghan M, Li W, et al. Prevalence of a Healthy Lifestyle Among Individuals With Cardiovascular Disease in High-, Middle- and Low-Income Countries. JAMA. 2013 Apr 17;309(15):1613–21. 47. Marques-Vidal P, Jankowski P, De Bacquer D, Kotseva K. Dietary measures among patients with coronary heart disease in Europe. ESC EORP Euroaspire V. Int J Cardiol [Internet]. 2020;302:5–14. Available from: https://doi.org/10.1016/j. ijcard.2019.12.064 48. Smedt D De, Backer T De, Petrovic M, Backer G De, Wood D, Kotseva K, et al. Chronic medication intake in patients with stable coronary heart disease across Europe : Evidence from the daily clinical practice . Results from the ESC EORP European Survey of Cardiovascular Disease Prevention and Diabetes ( EUROASPIRE IV ) Registry. Int J Cardiol. 2020;300:7–13. 49. Murphy A, Palafox B, O’Donnell O, Stuckler D, Perel P, AlHabib KF, et al. Inequalities in the use of secondary prevention of cardiovascular disease by socioeconomic status: evidence from the PURE observational study. Lancet Glob Health [Internet]. 2018;6(3):e292–301. Available from: http://dx.doi.org/10.1016/S2214-109X(18)30031-7 50. De Bacquer D, Astin F, Kotseva K, Pogosova N, De Smedt D, De Backer G, et al. Poor adherence to lifestyle recommendations in patients with coronary heart disease: results from the EUROASPIRE surveys. Eur J Prev Cardiol. 2022 Mar 11;29(2):383–95. 51. Turk-Adawi K, Supervia M, Lopez-Jimenez F, Pesah E, Ding R, Britto RR, et al. Cardiac Rehabilitation Availability and Density around the Globe. EClinicalMedicine. 2019 Aug 1;13:31–45. 52. De Smedt D, Clays E, Annemans L, Doyle F, Kotseva K, Pająk A, et al. Health related quality of life in coronary patients and its association with their cardiovascular risk profile: Results from the EUROASPIRE III survey. Int J Cardiol. 2013 Sep;168(2):898–903. 53. De Bacquer D, Dallongeville J, Kotseva K, Cooney MT, Pajak A, Deckers JW, et al. Residual risk of cardiovascular mortality in patients with coronary heart disease: The EUROASPIRE Risk Categories. Int J Cardiol. 2013 Sep;168(2):910–4. 54. Gupta R, Islam S, Mony P, Kutty VR, Mohan V, Kumar R, et al. Socioeconomic factors and use of secondary preventive therapies for cardiovascular diseases in South Asia: The PURE study. Eur J Prev Cardiol. 2015 Oct 18;22(10):1261–71. 55. McEvoy JW, Jennings C, Kotseva K, De Backer G, De Bacquer D, Erlund I, et al. INTERASPIRE: an International Survey of Coronary Patients; Their Cardiometabolic, Renal and Biomarker Status; and the Quality of Preventive Care Delivered in All WHO Regions. Curr Cardiol Rep. 2021 Oct 19;23(10):136. 56. Gupta R. Regional variations in cardiovascular risk factors in India: India heart watch. World J Cardiol. 2012;4(4):112. 57. Dandona L, Dandona R, Kumar GA, Shukla DK, Paul VK, Balakrishnan K, et al. Nations within a nation: variations in epidemiological transition across the states of India, 1990–2016 in the Global Burden of Disease Study. The Lancet. 2017 Dec;390(10111):2437–60. 58. Birk MG, Carvalho Goulart A, Lotufo PA, Martins Benseñor I. Secondary prevention of coronary heart disease : a cross-sectional analysis on the Brazilian Longitudinal Study of Adult Health ( ELSA-Brasil ). Sao Paulo Med J. 2019;137(3):223–33. 59. de Carvalho Costa IMNB, Silva DG da, Oliveira JLM, Silva JRS, Pereira LMC, Alves LVS, et al. Adherence to secondary prevention measures after acute coronary syndrome in patients associated exclusively with the public and private healthcare systems in Brazil. Prev Med Rep. 2022 Oct 1;29. 60. Marza Florensa A, Vaartjes I, Klipstein-Grobusch K, Zhao M, Cooney MT, Graham I, et al. Survey of risk factors in coronary heart disease: novel recruitment strategy and preliminary results. Eur J Public Health. 2021;31(Supplement 3). 61. Groenhof TKJ, Haitjema S, Lely AT, Grobbee DE, Asselbergs FW, Bots ML. Optimizing cardiovascular risk assessment and registration in a developing cardiovascular learning health care system: Women benefit most. Celi LA, editor. PLOS Digital Health [Internet]. 2023 Feb 8;2(2):e0000190. Available from: https://dx.plos.org/10.1371/journal. pdig.0000190 62. de Boer AR, de Groot MCH, Groenhof TKJ, van Doorn S, Vaartjes I, Bots ML, et al. Data mining to retrieve smoking status from electronic health records in general practice. European Heart Journal- Digital Health. 2022 Oct 3;3(3):437–44. 63. Samaras A, Bekiaridou A, Papazoglou AS, Moysidis D V, Tsoumakas G, Bamidis P, et al. Artificial intelligence-based mining of electronic health record data to accelerate the digital transformation of the national cardiovascular ecosystem: design protocol of the CardioMining study. BMJ Open. 2023 Apr 3;13(4):e068698. 64. Woldemariam MT, Jimma W. Adoption of electronic health record systems to enhance the quality of healthcare in low-income countries: A systematic review. BMJ Health Care Inform. 2023 Jun 12;30(1). 65. Zwisler AD, Rossau HK, Nakano A, Foghmar S, Eichhorst R, Prescott E, et al. The Danish cardiac rehabilitation database. Vol. 8, Clinical Epidemiology. Dove Medical Press Ltd; 2016. p. 451–6. 66. Ten Berg MJ, Huisman A, Van Den Bemt PMLA, Schobben AFAM, Egberts ACG, Van Solinge WW. Linking laboratory and medication data: New opportunities for pharmacoepidemiological research. Vol. 45, Clinical Chemistry and Laboratory Medicine. 2007. p. 13–9.
RkJQdWJsaXNoZXIy MTk4NDMw